"Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders." Neurology - Neuroimmunology Neuroinflammation
9.1
(2022):
e1100.
Web. 28 Sept2023.
Advertisement